V

VasoRx, Inc.

5 employees

VasoRx is developing RNA therapies for diseases of the cardiovascular system & oncology such as atherosclerosis and pulmonary hypertension.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical

Date founded

2018

Funding rounds raised

V

VasoRx, Inc. raised undisclosed on November 1, 2020

Investors: Good Ventures

FAQ